Jones Financial Companies
AVDL

Jones Financial Companies’s Avadel Pharmaceuticals AVDL Stock Holding History

Jones Financial Companies’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-500
Closed -$10.8K – 4734
2025
Q4 		$10.8K Buy
500
+50
+11% +$971 ﹤0.01% 3187
2025
Q3 		$6.9K Hold
450
– – ﹤0.01% 3228
2025
Q2 		$4.14K Buy
450
+200
+80% +$1.76K ﹤0.01% 3196
2025
Q1 		$2K Buy
+250
New +$2.09K ﹤0.01% 3241

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Jones Financial Companies's AVDL Position: Q1 2026 in Review

Jones Financial Companies sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 500 shares — an estimated $10.8K sold.

Jones Financial Companies first reported a position in AVDL in Q1 2025 and held it in 4 quarters. The position peaked at $10.8K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Jones Financial Companies reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jones Financial Companies sold 500 Avadel Pharmaceuticals shares in Q1 2026, an estimated $10.8K.
  • Jones Financial Companies first reported a position in Avadel Pharmaceuticals in Q1 2025 and held it in 4 quarters.
  • Jones Financial Companies's Avadel Pharmaceuticals position peaked at $10.8K in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.